Why the study?
Does percutaneous renal denervation lower blood pressure in patients with resistant hypertension compared to medical therapy?
Population
Patients with resistant hypertension, as well as those with systolic and diastolic heart failure, metabolic…
Comparison
Percutaneous renal denervation vs Medical therapy and/or sham control
Design
Review
Authors
Loading...
SYMPLICITY HTN-3 cautions against routine renal denervation in resistant hypertension; leaves open optimized trial designs for future evaluation.
Does percutaneous renal denervation lower blood pressure in patients with resistant hypertension compared to medical therapy?
This review summarizes the evolution of renal denervation trials, highlighting the negative results of SYMPLICITY HTN-3 and the subsequent redesign of clinical trials like SPYRAL HTN.
Pourafshar et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: